CUE BIOPHARMA INC (CUE)

US22978P1066 - Common Stock

1.58  -0.05 (-3.07%)

After market: 1.65 +0.07 (+4.43%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
5.49M1.25M14.94M3.15M3.46M
Operating Expenses
57.48M54.75M58.65M48.20M40.23M
Research and Development
40.28M37.76M40.19M32.59M26.75M
Selling, General, and Administrative Expenses
16.66M16.15M17.29M14.55M12.68M
Operating Income
-51.99M-53.50M-43.71M-45.04M-36.77M
Interest Income/Expense
1.42M210.00K20.00K460.00K420.00K
Other Income/Expense
N/AN/AN/AN/A60.00K
Non Recurring Items
-157.00K280.00KN/AN/AN/A
Income Before Taxes
-50.73M-53.01M-43.67M-44.58M-36.29M
Income Tax
N/A0.00500.00K210.00K410.00K
Net Income
-50.73M-53.01M-44.16M-44.78M-36.70M
EBITDA
-51.44M-52.58M-42.45M-43.98M-35.96M
 
Per Share Data
EPS Diluted Total Ops
-1.11-1.49-1.41-1.56-1.66
Non GAAP EPS
-1.11-1.50-1.40-1.56-1.67
 
Statistics
Profit Margin
-924.10%-4240.80%-295.58%-1421.59%-1060.69%
Operating Profit Margin
-947.03%-4280.00%-292.57%-1429.84%-1062.72%

All data in USD

Charts